ESTIMATED
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | $1.58 | $1.58 | $1.58 |
Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
Peak Bio, Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 607,681 for the year. Peak Bio, Inc. has generated $-1 earnings per share over the last year ($-0.74 diluted earnings per share) and currently has a price-to-earnings ratio of -0.01. Peak Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 4th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 08/18/2023 | Q2 2023 | -$0.29 | $0 | $0 | 07/11/2023 | Q1 2023 | -$0.32 | $13,854 | 06/29/2023 | Q4 2022 | -$0.74 | $607,681 | 09/30/2022 | Q3 2022 | -$0.01 | $110,000 | $0 | 06/30/2022 | Q2 2022 | -$0.13 | $0 | 03/31/2022 | Q1 2022 | -$0.10 | $52,950 | 12/31/2021 | Q4 2021 | -$0.51 | $528,309 | 09/30/2021 | Q3 2021 | $0.01 | $0 |
---|
A. Peak Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 4th, 2024 based off last year's report dates.
A. The conference call for Peak Bio, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Peak Bio, Inc.'s latest earnings report can be read online.
A. Peak Bio, Inc. (NASDAQ:PKBO) has a recorded annual revenue of $607,681.
A. Peak Bio, Inc. (NASDAQ:PKBO) has a recorded net income of $607,681. Peak Bio, Inc. has generated $-0.74 earnings per share over the last four quarters.
A. Peak Bio, Inc. (NASDAQ:PKBO) has a price-to-earnings ratio of -0.01 and price/earnings-to-growth ratio is -0.